• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1012622-59
Medical Device Problem Codes Difficult to Remove (1528); Stretched (1601); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Device Embedded In Tissue or Plaque (3165)
Date of Event 01/03/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H6: medical device problem code 2017 - against resistance.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion in the left common femoral artery and iliac with 100% stenosis, heavy calcification and mild tortuosity.Pre-dilatation was performed with a balloon.The 6.0x59mm omnilink elite stent delivery system (sds) was advanced into a 6french (f) sheath and advanced into the anatomy, however, the device could not cross to the target lesion and was removed from the anatomy.Another pre-dilatation was performed and this time more aggressively and the same omnilink elite sds was advanced but still failed to cross the lesion.Upon removal, the device was being pulled back into the 6f sheath with resistance and was being pulled out of the anatomy with resistance as well when the stent fully detached from the balloon into the external iliac, still unexpanded.A snare was attempted, but the stent could not be removed and started to elongate from the common femoral to the external iliac, as it seemed to be stuck in the calcification.Therefore, they went in with a non-abbott covered stent and embedded the stent where it remained, from the common femoral to the external iliac.The procedure was aborted at that point.There was an approximate 3 hour delay due to the issues.The patient was transferred to the hospital for overnight observation to be sure there was no internal bleeding or other complications due to the issues with the procedure.The patient was discharged the following day with no adverse patient sequela.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.It should be noted that the omnilink elite instructions for use, states: should unusual resistance be felt at any time during either lesion access or removal of the delivery system post-stent implantation, the entire system should be removed as a single unit.It is unknown if the ifu deviation directly caused or contributed to the reported event.The investigation determined the reported difficulties and subsequent device embedded in tissue or plaque in addition to unexpected medical intervention (additional therapy/non-surgical treatment) appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Common Device Name
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18567147
Report Number2024168-2024-01057
Device Sequence Number20878835
Product Code NIO
UDI-Device Identifier08717648179211
UDI-Public08717648179211
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P110043
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number1012622-59
Device Lot Number3051541
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 01/03/2024
Supplement Date Received by Manufacturer02/06/2024
Initial Report FDA Received Date01/23/2024
Supplement Report FDA Received Date02/23/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/15/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
6F SLENDER SHEATH
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age65 YR
Patient SexFemale
Patient Weight73 KG
-
-